Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). Emtricitabin/tenofoviralafenamid (HIV-Infektion): addendum zum auftrag A16-30; auftrag A16-58. [Emtricitabine/tenofovir alafenamide (HIV) - addendum to Commission A16-30] Cologne: Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). IQWiG-Berichte 446. 2016 Indexing Status Subject indexing assigned by CRD MeSH Adenine; Anti-HIV Agents; Emtricitabine; Germany; HIV Infections; Humans; State Medicine Country of organisation Germany English summary There is no English language summary available. Address for correspondence IQWiG, Im Mediapark 8, DE-50670 Cologne, GERMANY, Tel: +49 (0) 221 - 35685 - 0, Fax: +49 (0) 221 - 35685 - 1 Email: berichte@iqwig.de AccessionNumber 32017000122 Date abstract record published 18/01/2017 |